COVID Update: First data from an oral at-home anti-viral from Merck are in.
50% reduction in hospitalizations. Trial halted, EUA on the way. 1/
50% reduction in hospitalizations. Trial halted, EUA on the way. 1/
Game changer for COVID-19.
Will be able to be taken orally either post diagnosis or even after routine exposure. 2/
Will be able to be taken orally either post diagnosis or even after routine exposure. 2/
Added protection for some:
-breakthrough cases
-health care workers
Real potential for:
-countries/areas w low vaccine access or acceptance
-immunosuppressed
3/
-breakthrough cases
-health care workers
Real potential for:
-countries/areas w low vaccine access or acceptance
-immunosuppressed
3/
Clinical trials demonstrated effectiveness across variants including Delta.
4/
4/
There were 14 deaths in the placebo group and none in the group which took the anti-viral from what was reported to me of the data. 5/
There are 3 more drugs in advanced clinical trials— one with promising results. 6/
The tools to weaken COVID and make it manageable depend on oral-anti virals and other easily accessible therapies. 7/
We should begin manufacturing to flood the stores by the end of the year pending FDA approval. /end
• • •
Missing some Tweet in this thread? You can try to
force a refresh
